dm+d

413355004

Medicine Compliance Aid Stability

FampyraBiogen

Biogen
Fampyra
Tablets m/r 10mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Tablets should be used within 7 days of opening bottle
4 August 2016

Lactation Safety Information

No published evidence of safety
If considered essential monitor infant for neurological and GI effects related to its pharmacology
Its main use for improving walking in multiple sclerosis suggests its use could be discontinued during breastfeeding
23 September 2020